Adhesion of Candida albicans to host tissues is important in the hematogenous spread of the organism. Adherence to the vascular lining determines homing specificity resulting in targeting of specific organs and tissues. Analysis of leukocyte/endothelial-cell adhesion has demonstrated that the shear forces associated with blood flow dictate the type of adhesion receptor/ligand interactions that regulates the binding event. Adhesion of C. albicans to host tissue ligands have not been previously examined under shear; thus, it is not clear if any of the known C. albicans adhesins can function in blood flow. The objective of this project is to use novel, in vitro, flow adhesion assays and intravital microscopy to identify C. albicans shear-dependent adhesive interactions with host ligands. The following Specific Aims will be pursued. 1) Interactions between C. albicans and endothelial cells, platelets, marginating leukocytes, and extracellular matrix components will be examined under shear forces that approximate blood flow. 2) The role of known adhesins (C. albicans and host) in the interactions defined in Specific Aim 1 will be determined. 3) Identification and characterization of novel, shear-dependent adhesins will be sought. 4) Using intravital microscopy, interactions between C. albicans and vessels in exteriorized mouse mesentery will be done directly in the animal to confirm the importance of any interaction defined in the in vitro assays.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Boxx, Gayle M; Kozel, Thomas R; Nishiya, Casey T et al. (2010) Influence of mannan and glucan on complement activation and C3 binding by Candida albicans. Infect Immun 78:1250-9
Boxx, Gayle M; Nishiya, Casey T; Kozel, Thomas R et al. (2009) Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans. Mol Immunol 46:473-80
Zhang, Mason X; Bohlman, M Charlotte; Itatani, Carol et al. (2006) Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice. Infect Immun 74:362-9
Lillegard, Joseph B; Sim, Robert B; Thorkildson, Peter et al. (2006) Recognition of Candida albicans by mannan-binding lectin in vitro and in vivo. J Infect Dis 193:1589-97
Spellberg, Brad J; Ibrahim, Ashraf S; Avenissian, Valentina et al. (2005) The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice. Infect Immun 73:6191-3
Toenjes, Kurt A; Munsee, Suzanne M; Ibrahim, Ashraf S et al. (2005) Small-molecule inhibitors of the budded-to-hyphal-form transition in the pathogenic yeast Candida albicans. Antimicrob Agents Chemother 49:963-72
Cutler, J E (2005) Defining criteria for anti-mannan antibodies to protect against candidiasis. Curr Mol Med 5:383-92
Granger, Bruce L; Flenniken, Michelle L; Davis, Dana A et al. (2005) Yeast wall protein 1 of Candida albicans. Microbiology 151:1631-44
Ibrahim, Ashraf S; Spellberg, Brad J; Avenissian, Valentina et al. (2005) Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity. Infect Immun 73:999-1005
Sanchez, Angela A; Johnston, Douglas A; Myers, Carter et al. (2004) Relationship between Candida albicans virulence during experimental hematogenously disseminated infection and endothelial cell damage in vitro. Infect Immun 72:598-601

Showing the most recent 10 out of 63 publications